Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.06 USD | -0.33% | -6.80% | -15.72% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 102M | Sales 2025 * | 114M | Capitalization | 220M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -11M | EV / Sales 2024 * | 2.17 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.94 x |
P/E ratio 2024 * |
-15.6
x | P/E ratio 2025 * |
-19.2
x | Employees | 136 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.76% |
Latest transcript on OptimizeRx Corporation
1 day | -0.33% | ||
1 week | -6.80% | ||
1 month | +15.74% | ||
3 months | -24.39% | ||
6 months | +21.08% | ||
Current year | -15.72% |
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 12.06 | -0.33% | 170,294 |
24-05-30 | 12.1 | -0.41% | 73,761 |
24-05-29 | 12.15 | -4.03% | 104,699 |
24-05-28 | 12.66 | -2.16% | 92,009 |
24-05-24 | 12.94 | +5.20% | 168,923 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.72% | 220M | |
+22.55% | 426B | |
+31.87% | 276B | |
+4.92% | 135B | |
+6.46% | 92.01B | |
+23.70% | 89.16B | |
+57.95% | 58.86B | |
+11.34% | 45.03B | |
+19.19% | 34.77B | |
-10.48% | 31.93B |
- Stock Market
- Equities
- OPRX Stock